The Phase III Clinical Study of Herombopag for the Treatment of Thrombocytopenia in Chronic Liver Disease Patients Undergoing Elective Invasive Surgery
Clinical trial NCT06507436 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06507436
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2026-12-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.